BioSpace News Archive

Biotech Bay

Zomedica Pharmaceuticals Corp. Registration Statement Declared Effective by U.S. Securities and Exchange Commission

The Company will retain its listing on the TSX Venture Exchange (TSX-V).

November 21, 2017

·

4 min read

Titan Medical Announces Upsizing of Previously Announced Marketed Offering of Units

Each Warrant is exercisable for one Common Share at a price of CDN $0.60, for a period of five years following the closing of the Offering.

November 21, 2017

·

4 min read

BioMidwest

Elekta Debuts Magnetic Resonance Radiation Therapy System to Enable Precision Oncology Therapy at RSNA Annual Meeting

Elekta’s MR-linac integrates an advanced linear accelerator with a diagnostic-standard MR imaging system and intelligent software into a single device.

November 21, 2017

·

3 min read

Drug Development

DelMar Presents Positive Interim Results From VAL-083 Study in MGMT-Unmethylated Recurrent GBM at The Society for NeuroOncology Annual Meeting

DelMar reported that 96% of patients enrolled were alive at the time of the analysis and 40% of patients enrolled were reported to have achieved stable disease as assessed by MRI following treatment with VAL-083 as a single agent.

November 21, 2017

·

8 min read

Valeant Announces Closing of Add-On Secured Notes and Credit Agreement Amendment

Valeant used the net proceeds from the offering of the Notes, along with cash on hand, to prepay a portion of its outstanding Series F Tranche B Term Loans due 2022 and to pay related fees and expenses.

November 21, 2017

·

1 min read

Business

ImmunoCellular Therapeutics Announces Third Quarter 2017 Financial Results

For the quarter ended September 30, 2017, research and development expenses were $2.8M compared to $4.6M during the quarter ended September 30, 2016.

November 21, 2017

·

11 min read

Drug Development

Exelixis Announces Phase III CELESTIAL Trial Results of Cabozantinib in Previously Treated Advanced Hepatocellular Carcinoma to be Presented at 2018 Gastrointestinal Cancers Symposium

Exelixis to submit supplemental New Drug Application to the FDA in the first quarter of 2018.

November 21, 2017

·

13 min read

Pharm Country

Fujifilm Exhibits its Latest Innovations in Digital Radiography at RSNA 2017

The all new mini-digital X-ray system combines the high sensitivity of Fujifilm’s D-EVO II detectors and its refined image processing advancements to generate high resolution images with low patient dose.

November 21, 2017

·

4 min read

Policy

U.S. Stem Cell Responds to FDA’s Regenerative Medicine Guidelines

The framework is described among four FDA guidance documents that build upon its existing, risk-based regulatory approach, that further describes regulation of drugs, devices, and/or biological products.

November 21, 2017

·

4 min read

Pharm Country

Fujifilm to Showcase Advancements in Womens Health With Its ASPIRE Cristalle Digital Mammography System With Digital Breast Tomosynthesis at RSNA 2017

The ASPIRE Cristalle with DBT option combines state-of-the-art, HCP image capture technology and intelligent image processing, optimizing contrast and dose based on auto recognition of breast characteristics.

November 21, 2017

·

4 min read